Anti-ATM antibody [EPR17059]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
2
(1 Review)
|
(26 Publications)
Rabbit Recombinant Monoclonal ATM antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 26 publications.
View Alternative Names
Serine-protein kinase ATM, Ataxia telangiectasia mutated, A-T mutated, ATM
- IP
Supplier Data
Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)
ATM was immunoprecipitated from 1mg of HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysate with ab199726 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab199726 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : HEK-293 whole cell lysate 10ug (Input). Lane 2 : ab199726 IP in HEK-293 whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199726 in HEK-293 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-ATM antibody [EPR17059] (ab199726)
Predicted band size: 351 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)
ATM was immunoprecipitated from 1mg of SH-SY5Y (Human neuroblastoma from bone marrow cells) whole cell lysate with ab199726 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab199726 at 1/500 dilution (Panel A) or ab32420 at 1/500 dilution (Panel B). Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : SH-SY5Y whole cell lysate 10ug (Input). Lane 2 : ab199726 IP in SH-SY5Y whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199726 in SH-SY5Y whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds (Panel A and B).
All lanes:
Immunoprecipitation - Anti-ATM antibody [EPR17059] (ab199726)
Predicted band size: 351 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)
ATM was immunoprecipitated from 1mg of HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysate with ab199726 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab199726 at 1/500 dilution (Panel A) or ab32420 at 1/500 dilution (Panel B). Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : HEK-293 whole cell lysate 10ug (Input). Lane 2 : ab199726 IP in HEK-293 whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199726 in HEK-293 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds (Panel A and B).
All lanes:
Immunoprecipitation - Anti-ATM antibody [EPR17059] (ab199726)
Predicted band size: 351 kDa
false
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR17059] (AB199726)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/2000 dilution
Lane 1:
Rat testis lysate at 10 µg
Lane 2:
Mouse testis lysate at 10 µg
Lane 3:
293 (Human epithelial cells from embryonic kidney) whole cell lysate at 10 µg
Lane 4:
SH-SY5Y (Human neuroblastoma from bone marrow cells) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
Exposure time: 20s
- WB
Lab
Western blot - Anti-ATM antibody [EPR17059] (AB199726)
False colour image of Western blot : Anti-ATM antibody [EPR17059] staining at 1/2000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab199726 was shown to bind specifically to ATM. A band was observed at 350 kDa in wild-type A549 cell lysates with no signal observed at this size in ATM knockout cell line ab276095 (knockout cell lysate ab283834). To generate this image, wild-type and ATM knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/2000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
ATM knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human ATM knockout A549 cell line (<a href='/en-us/products/cell-lines/human-atm-knockout-a549-cell-line-ab276095'>ab276095</a>)
Lane 3:
HEK-293 cell lysate at 20 µg
Lane 4:
U-2 OS cell lysate at 20 µg
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR17059] (AB199726)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/5000 dilution
All lanes:
293 (Human epithelial cells from embryonic kidney) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR17059] (AB199726)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/2000 dilution
Lane 1:
Rat testis lysate at 10 µg
Lane 2:
Mouse testis lysate at 10 µg
Lane 3:
Mouse spleen lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
Exposure time: 3min
- WB
CiteAb
Western blot - Anti-ATM antibody [EPR17059] (AB199726)
ATM western blot using anti-ATM antibody [EPR17059] ab199726. Publication image and figure legend from Zhao, X., Guo, X., et al., 2018, Cell Death Dis, PubMed 29352124.
ab199726 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab199726 please see the product overview.
HBX specifically inhibits CHK2 phosphorylationa, b Western blot for γH2AX in control and HBX-expressing SUDHL-4 a, and DB b, cells with or without MTX treatment (4 ng/ml) for 48 h. c, d Western blot for DDR proteins (P-CHK2/CHK2/ATM and P-CHK1/CHK1) in control and HBX-expressing SUDHL-4 c, and DB d, cells with or without MTX treatment (4 ng/ml) for 48 h. e, f The mRNA levels of DDR proteins (ATM, CHK2, and CHK1) were largely unchanged in control and HBX-expressing SUDHL-4 e, and DB f, cells with or without MTX treatment. g,h The expression of the P-CHK2 downstream genes P53 and P21 in control and HBX-expressing SUDHL-4 g, and DB h, cells with or without MTX treatment. The results are shown as the mean ± SEM from triplicate experiments. GAPDH was used as a loading control
false
Related conjugates and formulations (1)
-
Anti-ATM antibody [EPR17059] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATM acts as a coordinator in cellular response to DNA damage highly interacting with multiple components of the DNA repair machinery. It forms a complex with proteins like NBS1 and MRN complex facilitating repair by recruiting and activating other proteins involved in homologous recombination and non-homologous end joining pathways. ATM also modulates p53 activity a primary response factor in cellular stress management linking ATM to control of cell cycle arrest and apoptosis. This positions ATM as an integral part of maintaining cellular integrity in face of genomic insult.
Pathways
ATM integrates neatly within the DNA damage response and cell cycle control pathways. ATM's operative relationship with the MRN complex and its role in the PI3K-related protein kinase family helps initiate appropriate repair processes upon DNA damage detection. Additionally ATM regulates the activity of proteins such as Chk2 which further propagates signals to p53 influencing decisions between cell cycle arrest and apoptosis. These interactions link ATM closely to essential processes like DNA repair and cell survival highlighting its role in genomic maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (26)
Recent publications for all applications. Explore the full list and refine your search
Aging 16:9692-9708 PubMed38843391
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer & metabolism 11:20 PubMed37932830
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 55:842-852 PubMed37227155
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:1244 PubMed36871014
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:492-512 PubMed36656721
2023
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36:e22495 PubMed35947121
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in nutrition 9:854655 PubMed35836584
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:4201287 PubMed35783188
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 21:859-870 PubMed35405736
2022
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 54:37-46 PubMed35130632
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com